DK1267847T3 - 5HT2-antagonist til regulering af IOP og behandling af glaucom - Google Patents

5HT2-antagonist til regulering af IOP og behandling af glaucom

Info

Publication number
DK1267847T3
DK1267847T3 DK00978627T DK00978627T DK1267847T3 DK 1267847 T3 DK1267847 T3 DK 1267847T3 DK 00978627 T DK00978627 T DK 00978627T DK 00978627 T DK00978627 T DK 00978627T DK 1267847 T3 DK1267847 T3 DK 1267847T3
Authority
DK
Denmark
Prior art keywords
iop
glaucoma
antagonist
regulation
treatment
Prior art date
Application number
DK00978627T
Other languages
English (en)
Inventor
Jesse A May
Anura P Dantanarayana
Original Assignee
Alcon Inc
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc, Yamanouchi Pharma Co Ltd filed Critical Alcon Inc
Application granted granted Critical
Publication of DK1267847T3 publication Critical patent/DK1267847T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00978627T 2000-03-17 2000-11-14 5HT2-antagonist til regulering af IOP og behandling af glaucom DK1267847T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19028800P 2000-03-17 2000-03-17
PCT/US2000/031246 WO2001070207A2 (en) 2000-03-17 2000-11-14 5ht2 agonists for controlling iop and treating glaucoma

Publications (1)

Publication Number Publication Date
DK1267847T3 true DK1267847T3 (da) 2004-03-08

Family

ID=22700724

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00978627T DK1267847T3 (da) 2000-03-17 2000-11-14 5HT2-antagonist til regulering af IOP og behandling af glaucom

Country Status (20)

Country Link
EP (1) EP1267847B1 (da)
JP (1) JP2003527415A (da)
KR (1) KR100499903B1 (da)
CN (1) CN1231214C (da)
AR (1) AR026707A1 (da)
AT (1) ATE258793T1 (da)
AU (2) AU1607101A (da)
BR (1) BR0017158A (da)
CA (1) CA2401969A1 (da)
DE (1) DE60008151T2 (da)
DK (1) DK1267847T3 (da)
ES (1) ES2210018T3 (da)
HK (1) HK1050143A1 (da)
MX (1) MXPA02008548A (da)
PL (1) PL358296A1 (da)
PT (1) PT1267847E (da)
TR (1) TR200400424T4 (da)
TW (1) TW546139B (da)
WO (1) WO2001070207A2 (da)
ZA (1) ZA200206852B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
WO2004054572A2 (en) 2002-12-13 2004-07-01 Alcon, Inc. Novel benzopyran analogs and their use for the treatment of glaucoma
US7476687B2 (en) * 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
WO2005058911A2 (en) 2003-12-15 2005-06-30 Alcon, Inc. Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
EP2400300A1 (en) 2004-08-25 2011-12-28 Takeda Pharmaceutical Company Limited Method of screening preventives/remedies for stress urinary incontinence
WO2006062839A1 (en) 2004-12-08 2006-06-15 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
EP2018863B9 (en) 2006-05-16 2015-02-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
JP5520051B2 (ja) 2007-11-15 2014-06-11 武田薬品工業株式会社 縮合ピリジン誘導体およびその用途
JPWO2011071136A1 (ja) 2009-12-11 2013-04-22 アステラス製薬株式会社 線維筋痛症治療剤
US20210052600A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Therapeutic agents for stress urinary incontinence and incotinence of feces

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5343298A (en) * 1997-01-13 1998-08-03 Yamanouchi Pharmaceutical Co., Ltd. 5-ht2c receptor agonists and aminoalkylindazole derivatives
WO2001040183A1 (en) * 1999-12-03 2001-06-07 Alcon Universal Ltd. 1-aminoalkyl-1h-indoles for treating glaucoma

Also Published As

Publication number Publication date
TW546139B (en) 2003-08-11
CA2401969A1 (en) 2001-09-27
WO2001070207A2 (en) 2001-09-27
DE60008151T2 (de) 2004-07-08
CN1450897A (zh) 2003-10-22
MXPA02008548A (es) 2004-08-23
KR20030095185A (ko) 2003-12-18
TR200400424T4 (tr) 2004-03-22
EP1267847B1 (en) 2004-02-04
ZA200206852B (en) 2003-08-27
WO2001070207A3 (en) 2002-05-10
AR026707A1 (es) 2003-02-26
DE60008151D1 (de) 2004-03-11
ATE258793T1 (de) 2004-02-15
PL358296A1 (en) 2004-08-09
PT1267847E (pt) 2004-05-31
JP2003527415A (ja) 2003-09-16
AU1607101A (en) 2001-10-03
EP1267847A2 (en) 2003-01-02
CN1231214C (zh) 2005-12-14
AU2001216071B2 (en) 2004-12-02
BR0017158A (pt) 2003-06-03
HK1050143A1 (en) 2003-06-13
ES2210018T3 (es) 2004-07-01
KR100499903B1 (ko) 2005-07-07

Similar Documents

Publication Publication Date Title
DK1112106T3 (da) Serotonerge 5HT2-agonister til behandling af glaukom
NO20035609L (no) Fremgangsmate for kontinuerlig naftabehandling
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1379224T3 (da) Guanylat-cyclase receptor-agonister til behandling af vævsinflammation og carciogenese
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DE60215179D1 (de) Dolastatin 10 derivate
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1392292T3 (da) Pyranoindazoler og deres anvendelse til behandling af glaukom
GB2402674B (en) Compositions and methods for the treatment of glaucoma or ocular hypertension
DK1411926T3 (da) Integrininhibitorer til behandling af öjensygdomme
DK1267847T3 (da) 5HT2-antagonist til regulering af IOP og behandling af glaucom
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
DK1344526T3 (da) Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
DK1257278T3 (da) Anvendelse af mirtazapin til behandling af sövnforstyrrelser
NO20035043D0 (no) Fremgangsmåte for behandling av okular hypertensjon og glaukom
DK1225890T3 (da) Rivastigmin til behandling af öjensygdomme
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
NO20025760D0 (no) S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser
NO20024381D0 (no) Behandling av okular hypertensjon og gluakom
NO20031779L (no) Fremgangsmåte og preparat for behandling av okular hypertensjon og glaukom